ALEX FAHOURY: Open Payments
NPI 1467406934 · BROCKPORT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,608 in 288 payments from 26 companies in 2025. Trend: 2023 $4,950 · 2024 $5,968 · 2025 $5,608
Food & beverage: $5,608
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 41 | $1,258 |
| ABBVIE INC. | 28 | $482 |
| Novo Nordisk Inc | 27 | $473 |
| Phathom Pharmaceuticals, Inc. | 35 | $447 |
| Lilly USA, LLC | 23 | $433 |
| PFIZER INC. | 26 | $379 |
| GlaxoSmithKline, LLC. | 13 | $310 |
| Amgen Inc. | 14 | $233 |
| Exact Sciences Corporation | 10 | $220 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $204 |
Products named: BREZTRI, FARXIGA, VOQUEZNA, MOUNJARO, TRELEGY ELLIPTA, VRAYLAR, Cologuard Collection Kit, Ozempic.
Industry payments across NY — which companies pay providers there.
